We have developed a template system for the prediction of CYP2D6-mediated metabolism of compounds. The system is composed of two types of two-dimensional templates (templates A and B), which were generated from mutually occupied areas of typical CYP2D6 substrates. The areas of templates are expressed as hexagonal blocks for application to the two-dimensional structures of chemicals. Experiments with 93 reactions with 69 typical substrates indicated the necessity for two similar but distinct shapes for template A (A1 and A2) for optimal placement. A frequently occupied area for substrates in template A1 was defined as a trigger area in which to capture a substrate for initiation of metabolism. Another frequently occupied area was found near the site of metabolism in template B. Both frequently occupied areas are linked to a pinching area. Occupancy of substrates on two template areas is suggested to be essential for the metabolism of CYPD6 substrates. In cases of CYP2D6 substrates without simultaneous occupancy of both areas, bimolecular placement, in which two molecules are placed coordinately, is proposed. Metabolism of small molecules, including naphthalene and quinoline, became explainable with the use of this idea. Validation of this template system with the use of both good and poor CYP2D6 substrates indicated clear advantages of the present system as a tool for drug modification, in addition to enabling highly accurate estimation of the site of metabolism.
Introduction
The cytochromes P450 (P450s) constitute a superfamily of hemecontaining enzymes that catalyze the metabolism of a variety of substrates. CYP2D6 is one of the major members of this family, because of its role in the metabolism of many drugs in clinical therapeutic use (Williams et al., 2004) . CYP2D6 shows extensive genetic polymorphism, which causes significant interindividual and ethnic differences in drug metabolism. Striking variations among poor and ultrarapid metabolizers are associated with individual differences in drug efficacy and safety (Dalén et al., 1997; Barclay et al., 2003) .
To evaluate efficiently the pharmacokinetic properties of drug candidates, facilitative assessment tools are necessary to provide medicinal chemists with information on substrate specificity and the site of metabolism, particularly in the early stages of drug discovery. Human-derived tissues and recombinant systems have been used to investigate the contributions of P450 forms and the sites of metabolism of chemicals, but these are usually resource-and time-consuming approaches.
CYP2D6 has broad substrate specificities and mediates the oxidation/reduction of small molecules such as naphthalene and large molecules such as emetine. Early observations of the involvement of basic drugs in metabolic reactions of CYP2D6 led to the proposal of a possible role of a basic nitrogen group in substrates in the interaction with protein residues at the metabolic site. Several predictive approaches, such as ligand-based models (Wolff et al., 1985; Meyer et al., 1986; Koymans et al., 1992; de Groot et al., 1999) and enzyme structure-based models (Islam et al., 1991; de Groot et al., 1996; De Rienzo et al., 2000) , have been developed to estimate CYP2D6-mediated metabolism. Those studies reported good predictability for the evaluation of substrate specificity. The prediction accuracy of ligand-based models, however, depends on the training set of compounds, whereas that of structure-based models might be affected by the quality of the crystal structure of the enzyme. Ligand-bound crystals may not always reveal the environment at the moment of oxidation/reduction of substrates. In addition, no structural interpretations are provided for especially negative results. A reliable tool providing clear interpretation of the judgment is necessary.
We have shown the advantages of flat template systems for simulated estimation and verification of metabolism data for human CYP2E1 , CYP2B6 (Koyama and Yamazoe, 2011) , and CYP4A11 (Yamaura et al., 2011) . In the present study, we constructed a unique template system applicable to both small and large substrates, to estimate and to elucidate the substrate specificity of CYP2D6, and evaluated its validity.
Materials and Methods
Materials. Experimental information concerning substrate specificity and the sites of metabolism was obtained from the literature. Published data obtained by using recombinant human CYP2D6 systems were adopted preferentially, because such data indicate the contribution of CYP2D6 distinctly. Ninety-five metabolic pathways for 71 CYP2D6 substrates, including relatively large and small, well-known substrates, were selected randomly and are summarized in Supplemental Table 1 , with the functional residues at the metabolic site, the functional residues close to the metabolic site (adjacent functional group), and the numbers of bonds and free rotatable bonds between the metabolic site and the adjacent functional group. ChemBio3D (version 12 for Windows; CambridgeSoft, Cambridge, MA) and ChemDraw (Windows and Mac OS; CambridgeSoft) were used to construct three-dimensional structures of the substrates and to overlay compounds. The structures were used for placement after energy minimization.
Construction of Template System. Four substrates were overlaid on the mianserin structure to optimize the mutual occupancy area after placement of their sites of oxidation in an identical area. In these overlaying experiments, the energy-minimized structures of the substrates were first generated. The structures were then transformed to various orientations and conformations by means of rotation of any rotatable bonds, if necessary. Hydrogen atoms of the substrates were not considered for placement. A draft template, which has two of sheets of combined hexagonal blocks, was extracted after manual optimization of the oxidation positions of four substrates. The draft template was further tested with the total 95 metabolic pathways for 71 substrates to define the substrate-interacting area and the space of the active site of CYP2D6. Initially, CYP2D6 substrates were applied to templates A and B as follows. A possible site of metabolism in a substrate was placed on the site of metabolism in template B. The connected position in the substrate was applied to the neighboring corner position on the template. The procedure was repeated until the substrate residue reached the bending (pinching) point of templates A and B. The rest of the substrate residue was laid on template A if the substrate had a suitable bending residue.
Observed common features of the substrate-interacting area and space were assumed to be the requirements for CYP2D6 substrates, and all compounds were overlaid to the draft template again. From the overlaid results, the substrate space at the active site of CYP2D6 was expressed as hexagonal shapes mimicking 2-dimensional structures of chemicals. The template system was defined with 2 planar templates, A1 and B, which were constructed with several hexagonal structures. The occupancy of atoms at each corner of the hexagonal Rings was evaluated. An atom that could not be placed exactly at the corner was counted as being located at the closest corner. The occupancy rate at each Position was calculated by dividing the number of placed atoms by the total number of reactions. A highly occupied region in template A1 was defined as a "trigger area." To determine the spatial limitations of the template system, placement of invalid metabolic reactions was also performed.
Validation of Template System. Validation of the template system was conducted by using good and poor substrates for CYP2D6. The suitability of the chemicals for the template system was examined by following a practical procedure described under Results.
Results
Molecular Similarity of CYP2D6 Substrates. A profile for the metabolized moiety in the substrates was surveyed initially on the basis of published data for CYP2D6. Various functional groups, including alkyl, alkoxy alkyl, alkyl amino, phenyl, methoxyphenyl, methylphenyl, and pyridinyl groups, were observed as the moieties of metabolism (Supplemental Table 1 ). In cases with alkyl amines located at the site of metabolism, aryl groups were frequently found as adjacent functional groups (e.g., N-demethylation of amitriptyline and N-deethylation of dexfenfluramine). In contrast, alkyl amino groups were often found as adjacent functional groups in cases with nonalkyl amines located at the site of metabolism (e.g., E10-hydroxylation of amitriptyline and 4-hydroxylation of atomoxetine).
Although most CYP2D6 substrates include a basic nitrogen atom, CYP2D6 is known to mediate the metabolism of chemicals with no basic nitrogen atom, such as phenytoin and spirosulfonamide. During the initial attempts in our study, we considered the idea of a functional group adjacent to the site of metabolism of CYP2D6 substrates interacting with CYP2D6, triggering or initiating a metabolic reaction. The idea is based on the localization of an electron-deficient or FIG. 1. Two-and three-dimensional structures of typical CYP2D6 -substrates. a, (R)-mianserin; b, mequitazine; c, (R)-mexiletine; d, perhexiline; e, tropisetron. The arrow for each two-dimensional structure indicates the site of metabolism. Chemical positions are indicated as numeric figures. A three-dimensional model of (R)-mianserin (black) was overlaid with those of four other substrates (gray). The sites of oxidation in the four substrates were adjusted to that of (R)-mianserin.
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Construction of Draft Template. (R)-Mianserin (Fig. 1a) , which has a rigid structure, was chosen as a prototype for extraction of a template for CYP2D6 substrates. A mequitazine model (Fig. 1b) was overlaid on the mianserin three-dimensional model to overlap C10a and C4a in the benzene ring of mequitazine with C5a and C9a of mianserin, respectively. Positions N1Ј, C2Ј, and C3Ј of mequitazine were overlaid with the N2-methyl, N2, and C3 positions, respectively. The (R)-mexiletine model (Fig. 1c) was overlaid at C2-methyl, C2, and C1 with C8, C9, and C9a of mianserin, respectively, and then the flexible moiety of the C1Ј, C2Ј, and nitrogen positions was fitted to the C5, C4, and C3 positions of mianserin. For perhexiline, the cyclohexane moiety (C1 to C6) of the three-dimensional model was first fitted to the mianserin benzene ring (C5a to C9a). These experiments afforded an overlapping position of the nitrogen atoms of both perhexiline and mianserin (Fig. 1d) . The fourth substrate, tropisetron, also was overlaid first at the benzene moieties (C3a to C7a of tropisetron with C5a to C9a of mianserin). Position C4Ј of tropisetron was in contact with position N2 of mianserin in this overlay (Fig. 1e) . These experiments showed mutually overlapped regions among five substrates of CYP2D6, which were extracted as a draft template. The draft template was composed of two planar areas, termed template A and template B, which contained at least two hexagonal Rings. The templates were connected as shown in Fig. 2a , with a dihedral angle of 130°.
Shapes of Templates A and B. With the use of 95 randomly selected reactions for CYP2D6 substrates, the draft template described above was defined. Although substrates interact with CYP2D6 at the active sites, these interactions are described hereafter as interactions with the CYP2D6 template, to facilitate explanation of the proposed modes of interaction.
Generated models for 72 of the 95 total reactions were able to be placed on the draft template (Fig. 3) . Twenty-one other reactions had similar shapes on template B area but differed slightly in the shape of the template A area (described in detail below as template A2). For the remaining 2 reactions (i.e., 14,15-epoxidation of arachidonic acid and 5-dehydrogenation of sparteine), suitable placements could not be obtained (described in supplemental material). All of the models for the 93 placeable reactions were applicable to the two-flat plate system with a bending position of approximately 130°. Two common features became apparent with these reactions, that is, bulky functional groups with thick space occupancies were rarely located on template B and tall residues of substrates were positioned around the wall behind but not in the facial side of template B in Fig. 3 Functional groups with electron-withdrawing effects, such as protonated amino (NH ϩ ) and fluorophenyl groups, were located at a specific area on template A (termed the trigger area and described below). Among those tested, acidic groups were placed in an area distal from the pinching point with few substrates but not on the middle or proximal end of template A from the pinching point.
To assess exactly the template occupancy of CYP2D6 substrates, the model structures were applied on the draft template to estimate the boundaries and shapes of both templates. Generated template A1, extracted from 72 reactions, and template B, extracted from all 93 reactions, are shown in Fig. 2b (the rings and positions were labeled with roman capital letters and numbers, respectively; to prevent confusion of positions of chemical substrates and templates, capital letters were used as "Rings" and "Positions" for template). Templates A1 and B are composed of 5 and 9 Rings, respectively. To generate the three-dimensional template system, Positions 1 and 14 of template A1 were overlaid on those of template B, to be located on the line of intersection of the two templates. The dihedral angle of the two templates was set at approximately 130°.
Relative usages of labeled Positions were determined as occupancy rates for the reactions that occupied templates A1 and B (Fig. 4) . Occupancy rates of other types of placements are shown in Supplemental Fig.  1 . Occupancy rates of more than 30% were detected for Positions 1 to 5 and Positions 9 to 14, which constitute Ring A and Ring B, respectively, on template A1. Another high-occupancy area was observed at Positions 22 to 32 (Rings F, G, and H of template B). Occupancy rates of more than 90% were detected at the pinching point (Position 1) and the middle side of Ring H. Ring areas showing high occupancy rates were consistent with the draft template area initially extracted with five typical substrates, which supports the essential use of Rings A and B on template A1 and Rings F, G, and H on template B.
The sites of metabolism were located mostly at Positions 27 and 28. Some chemicals were oxidized at Positions 48 or 49. These data suggest a minimal requirement for five carbon-carbon bond equivalents to connect the site of metabolism and the proximal end of the trigger area through the pinching (bending) area.
Properties of Chemical Moieties in Trigger Area of Template A1. Considering the case of template A2 described later, several functional groups, including pyridine, alkylamine, alicyclic amine, and benzene substituted with halogen, trifluoromethyl, sulfonamide, or alkyl ether/thioether groups, were found to be located in Ring B and a part of Ring A, especially at Position 13, areas of template A1 termed the trigger area in association with triggering or initiation of a metabolic reaction. Commonalities appeared for the residues in this placement. Benzene rings substituted with groups with electron-withdrawing effects, rather than simple benzene, were located at Ring B in the trigger area. Simple alkyl or alicyclic hydrocarbons and acidic groups were not found to be located in this area. Previously, the existence of a basic nitrogen atom 5 to 10 Å away from the site of metabolism had been proposed for CYP2D6 substrates (Wolff et al., 1985; Meyer et al., 1986; Koymans et al., 1992; de Groot et al., 1999) . Alkylamines are protonated under physiological conditions (pH 7.4), which produces electron-deficient spots. These data suggest the possibility that CYP2D6 attracts a functional group showing topical electron deficiency or a negative inductive effect in the trigger area.
For example, CYP2D6 mediates cyclohexyl oxidation of perhexiline but not oxidation of the piperidine ring. It is possible for the piperidine ring to lie on Ring H of template B (Supplemental Fig. 2) . One of the cyclohexyl groups is then placed on Ring B, and another group stands at Position 2 of Ring A. Position 2 has sufficient space to accept a cyclohexyl group of the size shown in the section of space above template A (described below). Therefore, poor oxidation of the piperidine ring of perhexiline is likely to be attributable to insufficient affinity of the cyclohexyl group in the trigger area. Although the functional entities of electronic force remain unclear, these functional groups can be used as markers for specific placements to verify CYP2D6 substrate specificity.
Typical Examples. Duloxetine undergoes CYP2D6-mediated 4-hydroxylation. It is possible for any one of the three functional groups of duloxetine (N-methylamine, thiophene, and naphthalene) to sit at either site for triggering and oxidation. Preferential uses of Rings H/F/G were observed during construction of template B (sections of shapes of templates A and B). Following the observed preference, the naphthyl group of duloxetine was placed on template B. For the reported 4-oxidation, the naphthyl group was expected to sit on Rings H and G, with ethereal oxygen at the pinching point (Position 1). It FIG. 4 . Occupancy rates at the hexagonal corner of the template system, for the reactions that occupied both templates A1 and B.
at ASPET Journals on June 20, 2017 dmd.aspetjournals.org was possible for the thienyl group of the other moieties to reside on Ring B of template A1, but the N-methylaminoethyl group would hamper placement. Instead, occupancies of the N-methylaminoethyl group on Rings A and B of template A1 and of thienyl group above the pinching area (around Position 14) were possible. The placement of the secondary amine at Position 11 fulfilled the requirement for the trigger role (Fig. 5a ). The naphthyl moiety resided at the site of oxidation in this placement. Consistent with the result of the constructed model, the 4-oxidation product was detected as the main metabolite in humans in vivo. In models of thienyl or N-methylaminoethyl group placements on template B, the bulky naphthyl group was around the pinching area, impeding stable seating. These modes of interaction are likely to contribute to the regioselectivity of duloxetine oxidation.
Chlorpromazine is metabolized to its 7-hydroxylated form by CYP2D6. Dimethyl amino and phenothiazine moieties were expected to be able to be placed on templates A1 and B, for triggering and oxidation, respectively. The conformity of the phenothiazine moiety to template B was examined by rotating the phenothiazine moiety on the template, considering the accommodation of the substituent group, chlorine atom, and dimethylamino alkyl moiety within the template, with preferential usage of Rings H/F/G and occupancy of the site of metabolism on Ring N. Only five placements were possible (Fig. 5,  b1-b5 ). Three placements occupied one Ring of Rings H/F/G and the other two placements occupied two of Rings H/F/G. In view of the predominant use of Rings H/F/G, the placement occupying Rings F/H might be the preferential one (Fig. 5b5) . For this placement, the nitrogen atom of the remaining dimethyl alkylamino moiety could be placed at Position 5 on Ring B and work in triggering (Fig. 5b6) . With this placement, the C7 carbon of the phenothiazine moiety at Position 28 would be oxidized, and the expected metabolite agrees with the observed in vivo human metabolite. In the placement of b4 in Fig. 5 , the nitrogen atom of the dimethyl alkylamino moiety could be placed at Position 3 on Ring B. However, the atom occupied only Ring G among the three preferentially used Rings. The expected 8-hydroxylated metabolite was not reported. In the case of aligning the dimethyl alkylamino moiety on template B, a large phenothiazine moiety was allocated around the pinching area but hardly accepted in the narrow template A area.
Construction and Properties of Template A2. As described above, 21 metabolic reactions of CYP2D6 were not placed in templates A1 and B. Each had an aromatic ring, which could be placed at the trigger area on template A1. The distance between the site of metabolism and the proximal end of the trigger area was only four carbon-carbon bond lengths, instead of the five bond lengths for template A1-type reactions (e.g., N-demethylation of tamoxifen). One possibility for this was a shift of the main trigger area from Ring B to Ring A, to reduce the minimal requirement for the bond length. Because of the trigger of the aromatic group, at least one bond needs to stretch before bending down in the template B direction. This structural limitation would produce a shift in the position of template B, which might reduce the chance for the moiety to enter the area of template B. The shift in the trigger area was unlikely to be the cause of accommodation within the CYP2D6 active site.
Another possibility considered was a 30°rotation of the aromatic group sitting on the trigger area (Ring B), which would reduce the bond requirements to reach the bending area (template A2). The introduction of template A2 allowed the metabolized parts of the chemicals in 21 reactions to be placed on template B (Fig. 2c) . Although the bond stretching from the aromatic moiety of the substrates could be placed at either Position 1 or 14 at the bending area, most of the aromatic substrates were explained on the basis of bending at Position 1. Typical uses of template A2 are shown with metoprolol and phenytoin, in comparison with their template A1 placements.
CYP2D6 mediates metoprolol oxidation to form the O-demethylated and ␣-hydroxylated metabolites. The alkoxyphenyl moiety, rather than the amino group, was expected to be placed in the Ring B area to form the major O-demethylated metabolite, as judged from the distance between the site of oxidation and the trigger area. The placement of the phenyl group on Ring B resulted in the extrusion of two carbon-carbon bond equivalents from the end of the template A1 area (Fig. 6a) . Similar placement of the alkoxyphenyl group on template A2 extruded a three-bond equivalent group, which allowed the terminal methyl group to reach the site of metabolism (Position 27) through Position 1 of the pinching point (Fig. 6b) . CYP2D6 mediates the formation of 3Ј,4Ј-dihydrodiol phenytoin. Application of the phenyl group to template A1 resulted in the boundary of the template area being exceeded (Fig. 6c) . The rotated placement of the phenyl group on template A2 kept another phenyl group within the boundary and directed to the site of oxidation (Fig. 6d) .
Distal End of Template A1. CYP2D6 mediates N-demethylation of tamoxifen. The alkoxyphenyl group was expected to sit at the trigger area. At first, the flattened structure was applied on both FIG. 5 . Placement of typical CYP2D6 substrates, duloxetine (a) and chlorpromazine (b), on the template system. a, The methylamino moiety of duloxetine is placed on template A1 with the nitrogen atom at Position 11, and the naphthyl moiety is seated on Rings H and G. The remaining thienyl moiety stands at Position 14. b, five possible placements of the phenothiazine moiety of chlorpromazine on template B (b1-b5) and the corresponding placement of the residual dimethylamino moiety on template A1 for placement b5 (b6). templates A1 and A2 (Fig. 7, a-c) . All three placements were hampered by residues exceeding the template A boundaries. Rotation of the rest of the tamoxifen residue to upright at the junction point of the alkoxyphenyl group and the double bond yielded a conformer on template A2 (Fig. 7e) . These data suggested that the substrate residues were not always necessary to stay on Ring C of template A1 or the equivalent area of template A2.
Space above Template A. The placement of tamoxifen on template A suggested a high ceiling space above the Ring C area, probably connected to entrance/exit for substrates of CYP2D6. Terfenadine undergoes oxidation of the tert-butyl group. The phenyl group of the tert-butylphenyl moiety was expected to sit on Ring G of template B (Supplemental Fig. 3) , with the nitrogen of piperidinyl group at Position 3 of Ring B for triggering. In this conformation, the diphenylmethanol group spread on both the lower and upper areas at the outside space of Ring C. Data on tamoxifen and terfenadine suggested the existence of an open space at the distal end of template A. As described for the draft template construction, bulky bicyclic amines of mequitazine and tropisetron were placed on the Ring B area. These data suggested that CYP2D6 had a space for tall residues, to accept at least a six-member ring in the region corresponding to the Ring B area.
As described for template A2 construction, phenytoin is oxidized mainly to 3Ј,4Ј-dihydrodiol, probably through the 3Ј,4Ј-oxide. The hydantoin ring of phenytoin was expected to lie at Positions 1 and 14 in the pinching area (Fig. 6d) .
Both the R-and S-enantiomers of citalopram undergo CYP2D6-mediated N-demethylation. These reactions might occur through either fluorophenyl or cyanophenyl group placement on the Ring B area of template A1. These data suggested that at least a tall chemical moiety such as fluorobenzene stood at Position 14 to lean against the wall behind (Supplemental Fig. 4a ).
CYP2D6 mediates O-demethylation of dextromethorphan and codeine. These reactions were expected to proceed through their Nmethyl nitrogen atoms on Ring B of template A. In these placements, the cyclohexyl rings stand at Position 1. These models suggest a high ceiling at Position 1 as well as Position 14 (Supplemental Fig. 4b) .
Diltiazem undergoes N-demethylation of the dimethylamino group. The reaction was expected to proceed through the trigger of the phenyl group on Ring B, with the methoxy phenyl moiety behind Rings B and C (Supplemental Fig. 4c ). These data suggest a space for tall and flat structures behind template A.
Pinching Point for Bending. The assembled structures of typical CYP2D6 substrates suggested bending in a specific area. In the present system, templates A and B are connected at Positions 1 and 14, with a specific angle of 130°. This angle was suggested from assembled structures of CYP2D6 substrates but not directly from bond angles of the connecting moieties of CYP2D6 substrates (Fig.  3) . Among the substrates with rigid structures, sparteine (2-dehydrogenation) showed 130°at the pinching area, but codeine and dextromethorphan showed ϳ140°(data not shown). A tolerance in the bending angle of ϳ10°was thus arbitrarily assumed. The overlaying results for rigid codeine and dextromethorphan suggested the feasibility of the current geometric configuration of the positions of the trigger area, pinching area, and site of metabolism.
Amide bonds are often located in the middle portions of chemicals, connecting terminal functional moieties (Supplemental Fig. 5 ). Such chemicals are rather poor substrates for CYP2D6, such as moclobemide (Härtter et al., 1996) , nateglinide, leflunomide, lidocaine, and flutamide. Poor catalysis was also detected with sulfoxides, such as (S/R)-omeprazole and lansoprazole. Tizanidine bends at the point of the secondary amino moiety, connected to both aromatic residues, and is a poor substrate for CYP2D6 (Granfors et al., 2004) . These data suggested a requirement for specific angle ranges in the pinching area, to hold stably near the site of oxidation.
Space of Template B. Template B contains an area between the pinching point and the site of metabolism. Application of a typical substrate suggested the spreading of flat structures on a total of 9 Ring areas of template B, on the basis of the superimposed models (Fig. 3) . Similar experiments with CYP2D6 substrates sitting on template A2 gave consistent results for the area of template B (data not shown).
Initial experiments with CYP2D6 substrates with sites of metabolism on their rings suggested that the site of metabolism was not confined to a specific point but was kept in an area (Ring N). Similar experiments with substrates with metabolizing sites at flexible alkyl moieties, such as alkyl amines and alkyl ethers, supported the assignment of sites at Positions 27, 28, 48, and 49 of Ring N. In addition, FIG. 6 . Applications of template A2 to metoprolol and phenytoin. a, the phenyl group of metoprolol is placed on Ring B and the alkyl amino moiety is extended in the direction of Ring C via Position 9. The methoxy moiety was extended to template B via Position 1, but the methyl group did not reach the sites of metabolic reactions (circles at the corners of Ring N). b, the phenyl group of metoprolol is placed on Ring BЈ of template A2. The alkyl amine moiety is extended in the direction of Ring CЈ. The methoxy moiety passes through Position 1 and is extended to template B. The methyl group of the methoxy moiety is placed at a site of metabolic reaction, Position 27. Therefore, O-demethylation by CYP2D6 is expected. c, one of the two phenyl groups of phenytoin is placed at Ring B and another phenyl group sinks at Position 2. This placement is not acceptable. d, one of two phenyl groups of phenytoin is placed on Ring BЈ. The other phenyl group passes through Position 1 and is placed on Ring H, with slight deviation. Positions 27 and 28 are sites of metabolic reactions. Numbers shown beside metabolic positions indicate the atom numbers of the substrate.
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The heights of substrates allowed to enter the areas of template B were also evaluated. On the whole, Rings H, N, M, and L, located on the left side to the bottom of template B, were judged to accept only flat chemical moieties. Placement of various chemicals, such as (R)-mianserin, suggested relatively high ceiling heights at Rings J and K, on the right side.
CYP2D6 mediates tert-butyl oxidation of terfenadine. Another tert-butyl-containing drug, terbinafine, was not reported to be oxidized by CYP2D6 but inhibited CYP2D6-mediated oxidation of drugs (Vickers et al., 1999) . These data indicated the possible placement of the tert-butyl group on template B (Supplemental Fig. 3 ). These data also suggested that the placement on Rings M and N was not limited to aromatic groups. The tert-butylphenyl group of terfenadine could be placed on Rings M and N. The tert-butyl group of terbinafine could also be placed in the same area, but the presence of a conjugated double-and triple-bond group next to the tert-butyl moiety caused an upward shift of the bending position and thus weakened the interaction at template A. These differences may be related to the inhibiting properties but poor substrate properties of terbinafine, although further study is necessary to understand the exact mechanism in detail.
Properties of Chemical Moieties on Template B.
A mutual structural property associated with template B was detected among published substrates of CYP2D6; none of their carboxylic or sulfonic acid moieties resided within the core interaction area on template B. Consistent with these observations, diclofenac does not undergo CYP2D6-mediated oxidation. A diclofenac derivative that replaced the carboxylic acid with a nonacidic alcohol was, however, reported to undergo oxidation of the aromatic ring (Mancy et al., 1999) . Phenol moieties, such as isoliquiritigenin, enter the template B area and are oxidized. The phenol group might represent the limit of acceptable acidic moieties on template B. These data suggested the possibility that the bulkiness, and not the acid property, was the factor to verify placement.
Application of Simultaneous Bimolecular Interactions. As described above, interactions of at least two distinct areas are necessary for CYP2D6 substrates. Several small chemicals are known as CYP2D6 substrates, but these do not fulfill the requirement of simultaneous placement on templates A and B. CYP2D6 mediates the oxidation of simple aromatic compounds, such as naphthalene and quinoline, but not toluene (Nakajima et al., 1997) . The former could be placed simultaneously in the trigger area on template A1, the pinching point, and the heavily used area of template B (Ring F and Ring G or Ring H), if two molecules were available simultaneously. However, the latter chemical did not satisfy the need for simultaneous placement at three positions. These ideas were tested with various chemicals.
CYP2D6 is known to mediate the metabolism of various small molecules such as phenacetin, acetaminophen, estragole, safrole, ipomeanol, and 2-or 4-nitroanisole (Fig. 8) . These chemicals were applied on both template A1 and template B and could be placed within the areas of both templates. In addition, aromatic groups of these substrates could be overlaid at Ring B of template A1 or Ring BЈ of template A2. Following the reported results on sites of CYP2D6-mediated metabolism, the sites were assigned around Ring N after application of the structures. Placements for favorable metabolism included at least one that occupied Positions 1 and/or 14. These areas were necessary for the interaction of the two molecules with each other. These results indicated selective occupancy in the pinching area as a marker to verify candidates as CYP2D6 substrates for small molecules.
The idea of colocalization of the two molecules can explain the substrate specificity of CYP2D6 as a unified mechanism. The rates of oxidation differ clearly among the substrates. Although ethoxycoumarin was placed for O-deethylation on template B, the deethylation was not or only slightly supported by CYP2D6 Sai et al., 1999) (Fig. 8) . The reason for the defective catalysis is unclear, but there are two possibilities, as for template A occupancy. One possibility is that placement of ethoxycoumarin on template A is excluded because of the rule for unavailability of acidic (lactone) residue on Rings A and B of template A1; another is that the O-ethyl group located at the pinching point hampers the placement at template B. The placement possibly occurs through occupancy of the phenyl group at Ring B or Ring BЈ. No detectable or poor catalytic activities are reported for small chemicals with O-alkyl groups, including 2-ni- FIG. 7 . Space at the distal end of template A and placement of tamoxifen. For N-demethylation, triphenyl parts are placed on template A1 (a and b) or A2 (c and d) . In each case, one or two phenyl groups cannot be placed within the area of template A. In the case of placement d, one phenyl group is placed on Ring BЈ. If the other two phenyl group are rotated around the indicated bond (curved arrow), then the phenyl groups stand above and beneath template A2, as shown in e. Flipping of the dimethylamino ether group with the stilbene group affords placement for 4-hydroxylation of the phenyl ring (position is shown at the side of the structure in placement d).
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Although a space above the pinching area accepted tall moieties of substrates in a unimolecular model, chemical moieties in bimolecular placement are unlikely to sit in a bay area outside Ring F. For example, 4-aminobiphenyl is a poor substrate for CYP2D6-mediated N-oxidation (Nakajima et al., 2006) . This was determined from the fact that the primary amino group exceeded the border of template B (Supplemental Fig. 6a ). Another placement of 4-aminobiphenyl allowed placement on template B, unless it otherwise inhibited the use of the extra area above Ring F. Similar situations were observed with 5-methylchrysene (data not shown).
CYP2D6 mediates the oxidation of 2-hydroxybiphenyl to 2,5-dihydroxybiphenyl. 2-Hydroxybiphenyl has no bending position in the molecule, except for the rotation of aromatic rings, which suggests an interaction with a bimolecular mechanism. On the basis of the preferential use of pinching areas and the scarce use of the upper region of Ring F, the occupancy of phenol group on Ring N and phenyl group on Ring F of template B was suggested (Supplemental Fig. 6b ). This placement on template B corresponded to the generation of the 5-hydroxylated metabolite. Another 2-hydroxybiphenyl molecule needed to sit on template A1 or A2. The placement did not fulfill the structural requirements for interaction on template A. The localization of an aromatic ring in the Ring B area was not satisfied because of the need for an interacting group in the Ring A area and exclusion of acidic groups on Rings A and B. These data suggested the use of Rings A and D for the phenyl and hydroxy phenyl groups, respectively. This placement does not fulfill the aromatic ring occupancy on Ring B but allows rigid interaction at the pinching area.
The formation of 7-, 9-, and 13-hydroxy and N-oxide derivatives of ellipticine is mediated by CYP2D6. Multiple placements were applicable for each reaction, and typical examples of placements are shown (Supplemental Fig. 7) . These experiments suggested that placements showing no or minimal exceeding spots beyond template B area also shared the heavy occupancies in Ring H and Positions 1 and/or 14. Although other placements were attempted, most of those placements had relatively large areas outside template B.
CYP2D6 mediates the oxidation of polyaromatic hydrocarbons. The enzyme mediates the 1-hydroxylation of pyrene at low rates. The result for pyrene was consistent with the present template model, which supports the idea of templates A1 and B obtained from the unimolecular placement model (Fig. 2 and Supplemental Fig. 8a) .
CYP2D6 is shown to mediate the oxidation of the endogenous steroids estrone and estradiol into the 2-hydroxy metabolites. The occupancy of the phenol group on Ring G and oxygen atoms of the phenol/carbonyl group at Position 47 offered a chance for the 2-oxidations (Supplemental Fig. 8, b and c) . The placements suggested localization of the angular methyl group (C18) at Position 37 and steroid ring D outside Positions 37 and 38.
Tranylcypromine is reported to inhibit CYP2D6-mediated oxidation (Salsali et al., 2004) . Atypical kinetic data suggested the simultaneous interaction of two molecules for the inhibition. These results were consistent with the idea of bimolecular placement of small molecules.
Whole Template Shape and Stepwise Procedure for Verification of CYP2D6 Substrates. With the use of the information described above, a practical procedure was developed, as indicated below. First, a two-dimensional structure of a test chemical is generated and applied to template B. A possible site of metabolism is placed in the area of Ring N, if the surrounding structure is kept within the template. The placement also needs to satisfy a requirement directing the rest of the chemical moiety to take the way to the upper side (mostly Positions 1 and/or 14). The chemical moieties placed on template B have mostly flat shapes, but a bulky moiety, such as a tert-butyl group, is allowed to be placed on the distal end of template B, such as in terfenadine. Positions 1 and 14 (pinching area) correspond to the height level of template A1/A2. The extending moieties from the structure on template B need to have properties that allow bending in the direction of template A1/A2, as shown in Fig. 3 .
Few chemicals bend from higher Positions, such as Positions 35 and 36. Tall groups, such as fluorophenyl or cyclohexyl groups, can be located in this area, as shown with (R)-citalopram. In addition, there may be an extra area outside Ring J that can accept a five-or six-membered ring, as described for estradiol/estrone.
Chemical groups sitting on template A1/A2 are required to take flat-bottom shapes, although structures with at least a six-membered ring height sit on the middle part. Chemicals showing tall shapes on template A1, such as tamoxifen, often conform to lean against a wall expected around Positions 15 to 21 (Fig. 7) . The outside of the distal end from the pinching point is likely to have an open space on both the bottom and the top, which may connect to the entrance/exit of CYP2D6.
Among the keys to verify the placement on template A1/A2 are the electronic properties of chemicals exposed to the ground of template A1/A2. Amines protonated under physiological conditions (pH 7.4) and phenyl group substituted with groups with electron-withdrawing characteristics, such as halogen atoms, often are located on Ring B. Some amino groups are located on Ring A instead of Ring B. Acidic moieties, including lactones, are located on Ring C but not on Rings A and B. For a limiting example of the suitability, occupancy on Ring B by a phenyl group but not a cyclohexyl group is possible in the simulated placement. Although the exact mechanism for the requirement for the electronic properties remains unclear, somehow these properties are involved in the holding of CYP2D6 substrates at the trigger area (Rings A and B) of template A1. As described above (Fig.  2c) , some CYP2D6 substrates with phenyl rings around the Ring B area did not overlay well on Positions of template A1. Template A2 is applicable to these chemicals. Finally, accommodations of chemicals in the template are checked by using ChemBio3D.
These procedures are repeated for all possible conformers and orientations of a test chemical, to investigate the site of metabolism and to assess the preferential placement. Among all of the possible placements, suitable placements are judged on the basis of the occupancy rates. For example, if the difference in two placements is whether they occupy Ring G or Ring H, then the placement with Ring H occupancy is superior to the other.
Test chemicals were verified against two distinct criteria, namely, spatial accommodation and area-specific interactions. Interaction in the Ring B/A area on template A1 or Ring BЈ area on template A2, probably through electrostatic forces, and occupancy of the Ring H area and pinching area (Positions 1 and 14) are suggested to be linked to the dominant placement in cases of possible multiple placements. Although the practical procedures described above are applicable to many chemicals, it is also possible to start fitting from the trigger area of template A, followed by extension to template B.
Possible Unique Placements. CYP2D6 mediates the metabolism of a wide variety of compounds. Cases of possible unique placements are described in the supplemental data, including application of the template system to clozapine ( Supplemental Fig. 9) ; spirosulfonamide (Supplemental Fig. 10) , which is well known as a substrate without a basic nitrogen atom in its structure; pitavastatin ( Supplemental Fig.  11) ; debrisoquine (Supplemental Fig. 12 ) and sparteine (Supplemental Fig. 13) , which are well known as prototypic substrates in the development of prediction models; arachidonic acid (Supplemental Fig.  14) , which could not be explained in the current experiment; and quinidine (Supplemental Fig. 15 ), which is an inhibitor of CYP2D6.
Validation of Template System. CYP2D6 substrates and poor substrates that were not used to construct the template system were used to evaluate the accuracy of the estimation of the template system. Among 54 reactions of CYP2D6 substrates, CYP2D6 was judged to mediate 50 reactions (93%) with this template method. The sites of the oxidation were also concordant with reported data. Of the 61 substrates with poor or absent CYP2D6-mediated reactions, 60 reactions (98%) were judged as unlikely to be mediated by CYP2D6 (Supplemental Table 2 ).
Discussion
Although the versatile substrate specificity of P450 enzymes is often explained in terms of the flexibility of P450 proteins, a model with a rather constant core shape for the CYP2D6 active site was developed in the present study. To simulate the active site, two template sheets with specific hexagonal shapes were combined. In addition, atoms of substrates were assumed to be located on the corners of the hexagonal blocks of the template. Three major forces are set on the combined template system to interact with ligands. One is located near the area of metabolic reaction on template B. A second force is placed at the connected position of the two templates, termed pinching area in the present study. A third force is placed on template A1 or template A2. The force may be associated with stable holding of ligands inside the active site of CYP2D6 and also with triggering of the enzymatic reaction. To support this idea, simultaneous bimo- dmd.aspetjournals.org Downloaded from lecular placement was introduced. These ideas were verified with more than 50 typical substrates of CYP2D6.
High occupancy rates at specific Positions on the template system were detected among the overlays of typical substrates. Each position of Ring H showed a more than 70% occupancy rate. This area was linked to the area with the second highest occupancy rates (Ring G), to the area of metabolism (Positions 27, 28, 48, and 49 of Ring N) , and also to the pinching area (Positions 1 and 14) . These configurations suggest a possible role of Positions 27, 31, and 32 (showing almost 100% occupancy) on Ring H. These Positions may play a role in the bending and the holding of the metabolized group of substrates near the area of metabolism. Another highly used area was observed in Ring A and Ring B on template A1. Chemical groups sitting on these Rings are characterized as having electronic forces of protonated nitrogen atoms or an aromatic ring with substituents with negative inductive effects. These forces are better explained as facing to the ground of template A but not direct above or toward side spaces in the present study, although the basic nitrogen atom was shown to interact with side spaces in a docking model. The exact roles of these forces are yet unclear, but the identification of the possible force direction allows us to select conformations of substrates on template A.
At the pinching area where template A and template B are connected, structures of CYP2D6 substrates bend with interior angles of ϳ130°. Tall substituents are able to stand at Position 1 and Position 14, and thus the force to press down chemical moieties to the ground of template B may be located on template B.
A characteristic placement of template B was suggested for bimolecular substrates. The occupancy of the aromatic ring in the bay area above the pinching area was excluded to explain the substrate specificity of CYP2D6 on ellipticine. All of the tested chemicals fulfilled the restriction for bimolecular placement. This idea was supported by the lack of the N-oxidation of 4-aminobiphenyl (Supplemental Fig. 6 ). These data suggest the existence of specific requirements for bimolecular placement. This may be interpreted as preventing a substrate molecule from protruding in template B. In addition, poor rates of oxidation were observed for large substrates with bimolecular placement, such as estrone, 5-methylchrysene (Koehl et al., 1996) , and benzo[a]pyrene (Arlt et al., 2003 (Arlt et al., , 2004 . Despite the accommodation within template B, CYP2D6 is known to have scarce activities for the oxidation of polyaromatic hydrocarbons, such as phenanthrene 9-hydroxylation, pyrene 4-hydroxylation, and benzo[a]pyrene dihydrodiol formation. Data on localization of the angular methyl group of estrogen and the tertiary butyl group of terfenadine suggest the possibilities of bending or delineation of the terminal Rings of template B. These bendings might make it possible to prevent polyaromatic hydrocarbons from the intense interaction with template B. Additional studies are necessary to characterize in detail the peripheral environments of template B. Therefore, these templates do not necessary reflect the actual interactions of CYP2D6.
CYP2D6 has broad substrate specificities. Therefore, most prediction systems reported previously, such as ligand structure-based pharmacophore models and enzyme structure-based homology models, are applicable to certain categories of chemical ligands but not to all substrates of CYP2D6 (Moors et al., 2011) . The present system has shown applicability to a wide variety of chemicals as a unified system. Clear depiction of the boundary area of the CYP2D6 active site is another advantage of this system. Reliable prediction of the regioselectivity and stereoselectivity of CYP2D6 became possible through estimation of the boundary positions. This system offers clear interpretations of judgments regarding substrate/poor substrate estimations, in terms of chemical residues. Therefore, this method is usable as a tool for the refining process for seed compounds, as well as in drug metabolism studies.
The present system showed high accuracy regarding substrate/poor substrate estimations and regioselectivity/stereoselectivity in the tests using chemicals that were not used for the construction of templates. A few chemicals remain unspecified. Pactimibe (2-[7-(2,2-dimethylpropanoylamino)-4,6-dimethyl-1-octyl-2,3-dihydroindol-5-yl]acetic acid) is a large substrate of CYP2D6. The tert-butyl group does not reside completely within template A1. This may be related to a pocket in the wall behind template A1, but additional studies are necessary to determine the wall shape precisely. The preference order of metabolism also remains unresolved. For example, pyrene is reported to undergo CYP2D6 oxidation to 1-hydroxypyrene. Formation of 4-hydroxyprene is not detected. Both 1-and 4-oxidations are suggested by the current system. This phenomenon may be associated with the preferential use of specific Ring areas on template B. We observed similar phenomena in the prediction of CYP2E1 metabolism. We are currently applying a computer-based, Positiondependent scoring method to evaluate CYP2D6 metabolic reactions more rigorously.
We also applied the template system to a few inhibitors of CYP2D6. From those preliminary experiments with inhibitors, the template system is suggested to have potential use for the evaluation of CYP2D6 inhibitors in a way similar to that for substrates. We are planning to report the results of the applications to CYP2D6 inhibitors separately.
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